Industry Insights

  1. RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters 2/25/2026

    Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

  2. Choosing RTSM? Evaluate The Team Running It, Not Just The Software 2/25/2026

    High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

  3. Automation Testing In RTSM Software: What Is It And What's The Impact 2/25/2026

    Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.

  4. How Modern RTSM Platforms Are Eliminating Delays 2/25/2026

    Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.

  5. 3 Reasons Sponsors Should Own The RTSM Vendor Relationship 2/25/2026

    Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.

  6. Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1) 2/25/2026

    Understand why cloud infrastructure is foundational to hybrid and decentralized trials and what critical trial activities it enables with reduced operational friction.

  7. Why Sponsors Should Share KPI Rationale With Sites 2/25/2026

    To build partnerships, foster transparency, and promote shared accountability, Curo Research CEO Amy Bland explains why sponsors need to communicate the utility of KPIs with sites.

  8. Safe And Sustainable DCTs and Hybrid Trials (Part 2) 2/25/2026

    In part two of this series, learn practical cloud architectural patterns, governance structures, and operating mechanisms that allow sponsors to run hybrid and decentralized trials.

  9. Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk 2/24/2026

    Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.

  10. Reduction Of Screen Failures In A Biomarker 2/24/2026

    Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.